3 New Strong Buy Ratings from Top-Rated Analysts: 04/16/2026

By Jessie Moore, Stock Researcher and Writer
April 16, 2026 5:55 AM UTC
3 New Strong Buy Ratings from Top-Rated Analysts: 04/16/2026

We’ve got a fresh wave of Strong Buy ratings, just for you:

  • SanDisk Corp (SNDK) — Up 2,200% in a year riding the AI wave
  • Gilead Sciences Inc (GILD) — Top-rated pharma giant with a $5B oncology bet
  • Penguin Solutions Inc (PENG) — Under-the-radar AI infrastructure play beating estimates

P.S. Get more alerts like this daily … Try WallStreetZen Premium.

 


A note from our sponsors...

Buffett's $114 Secret In 1943, a teenage Warren Buffett put $114 into a special type of account called "The 29% Account." Today, that single, $114 investment would be worth over $15 million. Your bank never told you about this. Click Here to See How It Works

1. Gilead Sciences Inc (NASDAQ: GILD)

Gilead Sciences is a leading biopharma company behind some of the most important HIV and hepatitis treatments worldwide. Now, it's making a bold push into oncology with a $5B Tubulis acquisition — signaling a major new growth chapter ahead.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $140.00 — get current quote

Max 1-year forecast: $180.00

Why we're watching:

  • Analyst support: GILD enjoys impressive coverage with 10 Strong Buy ratings, 2 Buy ratings, and 2 Hold ratings among 14 analysts we track, reflecting strong confidence in the company's direction. See the ratings
  • Needham's Joseph Stringer (a top 1% rated analyst) reiterated a Buy rating with a $170 price target (suggesting over 20% potential upside), highlighting the company's robust pipeline and effective strategy.  
  • Industry ranking context: GILD is currently the 1st highest-rated stock in the General Drug Manufacturer industry, which has an Industry Rating of A. (Learn more about our Industry Ranking here.)
  • Zen Rating highlights: As a Strong Buy stock, GILD ranks in the top 5% of tickers we track based on a sturdy 115-factor review. 
  • Component Grades: Looking at the Component Grades that make up that overall score, GILD earns impressive As for Financials and Value and Bs for Sentiment, Safety, and Momentum. See all 7 Zen Component Grades here

2. Penguin Solutions Inc (NASDAQ: PENG)

Penguin Solutions builds enterprise solutions across Advanced Computing, Integrated Memory, and Optimized Solutions. As enterprises, governments, and neocloud providers race to deploy AI factories, Penguin is emerging as a key player — especially with its MemoryAI™ CXL-based solutions powering AI inference workloads.

Zen Rating: B (Buy)see full analysis

Recent Price: $25.73 — get current quote

Max 1-year forecast: $32.00

Why we're watching:

  • Analyst support: PENG enjoys a perfect buy-side consensus with 2 Strong Buy and 1 Buy rating among 3 analysts, with zero Hold, Sell, or Strong Sell ratings. See the ratings
  • Rosenblatt's Kevin Cassidy (a top 1% rated analyst) recently raised the price target to $32 following Q2 2026 earnings, highlighting that the company added five new AI/HPC customers including a Tier One financial institution deploying MemoryAI™ solutions.
  • Stifel Nicolaus' Brian Chin (top 2%) maintained a Strong Buy rating with a $24 price target, recognizing the company's expanding customer base beyond hyperscalers as an important indicator of consistently profitable growth.
  • Good guidance: Management raised full-year guidance to 7%-17% revenue growth following a Q2 beat, with EPS of $0.52 (beating estimates by 20.93%) demonstrating strong execution despite challenging market conditions.
  • Industry ranking context: PENG is currently the 4th highest-rated stock in the Semiconductor industry, which has an Industry Rating of B.
  • Zen Rating highlights: Buy (B) stocks average +19.88%/yr, meaning PENG is in a category of proven outperformers. 
  • Component Grades: Looking at the Component Grades that shape the overall score, PENG demonstrates several areas of strength, including an A for Value and Sentiment and a B for Financials, reflecting the company's attractive valuation and strong growth trajectory. See all 7 Zen Component Grades here

3. SanDisk Corp (NASDAQ: SNDK)

SanDisk develops storage devices and solutions built on NAND flash technology, from solid state drives to embedded and removable storage. The stock has skyrocketed over 2,200% in the past year as the AI boom fuels massive demand for memory solutions — and it's about to join the Nasdaq-100 Index on April 20, 2026.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $937.00 — get current quote

Max 1-year forecast: $1,000.00

Why we're watching:

  • Analyst support: SNDK enjoys strong Wall Street backing with 9 Strong Buy ratings, 3 Buy ratings, and 4 Hold ratings among 16 analysts, delivering a Strong Buy consensus. See the ratings
  • Cantor Fitzgerald's C.J. Muse (a top 2% rated analyst) recently maintained a Strong Buy rating with a $1,000 price target, representing 17.4% upside even after the massive rally.
  • Bank of America's Wamsi Mohan (top 1%) set a $900 price target, while Citigroup's Asiya Merchant (top 1%) targeted $875, both maintaining Strong Buy ratings.
  • Morgan Stanley's Joseph Moore (top 1%) and Jefferies' Blayne Curtis (top 1%) both highlighted the company's position as a pure-play NAND winner in the AI boom.
  • SNDK is also part of our Zen Investor portfolio, where Editor-in-Chief Steve Reitmeister still rates SNDK a Strong Buy despite the fact that it’s already gained 70% since its addition to the portfolio. See more of the stocks in the portfolio here.
  • Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr, putting SNDK in the top tier of stocks we track based on a 115-factor review. 
  • Component Grades: Looking at the Component Grades that shape the overall rating, SNDK earns an A for Growth and Sentiment, and Bs for Momentum and Financials, reflecting the company's exceptional growth trajectory balanced against its rapid valuation expansion. See all 7 Zen Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.